Allogene Therapeutics (NasdaqGS:ALLO) Q4 2025 Earnings call March 12, 2026 05:00 PM ET Company ParticipantsChristine Cassiano - EVP, Chief Corporate Affairs, and Brand Strategy OfficerDavid Chang - President and CEOGeoffrey Parker - EVP and CFOSalveen Richter - Managing DirectorZachary Roberts - EVP of Research and Development and CMOConference Call ParticipantsAsthika Goonewardene - Equity Research Analyst and Managing DirectorBiren Amin - Managing Director and Senior Research AnalystBrian Cheng - VP and E ...